Touchlight, a biotechnology company specializing in cell-free DNA manufacturing, has partnered with SVF Vaccines to progress SVF’s Hepatitis B/D vaccine into clinical development. The collaboration leverages Touchlight’s proprietary doggybone DNA (dbDNA) platform, a scalable enzymatic DNA technology designed to meet the growing global demand for genetic medicines and recognized for its manufacturability and functional advantages compared to traditional plasmid DNA (pDNA). Importantl...